New York Life Investment Management LLC

Position in ELAN — Elanco Animal Health Inc

CIK 1133639 New York, NY

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,511,152

+$21,654 QoQ

Shares Held

61,404

-1.3% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#204

of 515 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

New York Life Investment Management LLC holds $14,583,179 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	71,601	$5,145,247
2	VTRS	Viatris Inc	306,470	$4,866,743
3	NBIX	Neurocrine Biosciences Inc	14,832	$2,499,785
4	ELAN	Elanco Animal Health Inc This page	61,404	$1,511,152
5	UTHR	UNITED THERAPEUTICS Corp	1,034	$560,252
6			466,632	$0

All Filings in ELAN

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,511,152	61,404	-1.3%	Shares	Sole	2026-08-10
2026-03-31	$1,489,498	62,244	+48.5%	Shares	Sole	2026-05-07
2025-12-31	$948,264	41,903	—	Shares	Sole	2026-02-05
No filing history on record for this holder in this stock.